TrialBMC research notes2015

A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.

Hiroyuki Minemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.